These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 21225122

  • 21. Comparison of techniques of botulinum toxin injections for blepharospasm and hemifacial spasm.
    Sacramento DRC, Lima A, Maia DP, Cunningham M, Maciel RH, Camargos ST, Cardoso F.
    Mov Disord; 2019 Sep; 34(9):1401-1403. PubMed ID: 31251420
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Costs and efficacy of type A botulinum toxin for the treatment of essential blepharospasm and hemifacial spasm].
    Lasalvia CG, Pereira Lde S, da Cunha MC, Kitadai SP.
    Arq Bras Oftalmol; 2006 Sep; 69(5):701-5. PubMed ID: 17187139
    [Abstract] [Full Text] [Related]

  • 26. Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study.
    Rollnik JD, Matzke M, Wohlfarth K, Dengler R, Bigalke H.
    Eur Neurol; 2000 Sep; 43(1):9-12. PubMed ID: 10601802
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pain relief in patients receiving periocular botulinum toxin A.
    Harrison AR, Erickson JP, Anderson JS, Lee MS.
    Ophthalmic Plast Reconstr Surg; 2008 Sep; 24(2):113-6. PubMed ID: 18356715
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
    Thussu A, Barman CR, Prabhakar S.
    Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
    [Abstract] [Full Text] [Related]

  • 35. Lid wiper epitheliopathy in patients with blepharospasm and/or hemifacial spasm.
    Romero-Caballero MD, Salmerón Ato MP, Palazón-Cabanes A, Caravaca-Alegría A.
    Arch Soc Esp Oftalmol (Engl Ed); 2022 Jul; 97(7):376-380. PubMed ID: 35292220
    [Abstract] [Full Text] [Related]

  • 36. Effect of Botulinum toxin A application in neuro-ophtalmologic indications on Schirmers test and tears osmolarity.
    Žiak P, Halička J, Kapitánová K, Mojžiš P.
    Cesk Slov Oftalmol; 2019 Jul; 75(2):74-77. PubMed ID: 31537075
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K.
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [Abstract] [Full Text] [Related]

  • 40. The effect of botulinum toxin a treatment on tear function parameters and on the ocular surface.
    Horwath-Winter J, Berglöff J, Flögel I, Haller-Schober EM, Müllner K, Schmut O.
    Adv Exp Med Biol; 2002 Mar; 506(Pt B):1241-6. PubMed ID: 12614060
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.